RxDoctor Payments Data

Deborah Ocasio, MD

Psychiatry · Guttenberg, NJNPI 1972764983

Payments from drug & device makers

$653in general payments, 2019–2025

Across 34 payments — averaging $19.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neuronetics, Inc.$265
  • Almatica Pharma LLC$155
  • E.r. Squibb & Sons, L.L.C.$47
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$41
  • Otsuka America Pharmaceutical, Inc.$39
  • AbbVie$38
  • plus $67 from 4 others

What the payments were for

  • Food & beverage$653100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$653 in reported general payments places this provider in the 65th percentile of 1,119 psychiatry providers in New Jersey.

See all psychiatry providers in New Jersey

Medicare billing

Part B allowed, 2024
$191,953
Medicare patients
360
Services billed
1,193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AtivanLorazepam13$53,137
VraylarCariprazine Hcl22$31,163
Lurasidone Hcl20$16,764
TrintellixVortioxetine Hydrobromide12$11,792
Bupropion XlBupropion Hcl149$10,037
Venlafaxine Hcl ErVenlafaxine Hcl332$9,551
Aripiprazole124$7,653
Quetiapine Fumarate303$7,336
Divalproex Sodium156$7,321
Olanzapine291$6,500
Clonazepam365$6,356
Mirtazapine223$6,144
BelsomraSuvorexant13$5,654
Ziprasidone Hcl30$5,358
Escitalopram Oxalate306$4,713

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$38$31,16322 claims
Almatica Pharma LLCSertraline Hcl$155$2,609187 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,119 psychiatry providers in New Jersey.

Other psychiatry in Guttenberg

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →